United States

Enzo Biochem Inc (ENZ.N)

ENZ.N on New York Stock Exchange

21 Oct 2016
Change (% chg)

$0.01 (+0.17%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for ENZ.N


Enzo Biochem, Inc. (Enzo) is an integrated life science and biotechnology company, which is engaged in the research, development, manufacturing and marketing of diagnostic and research products based on genetic engineering, biotechnology and molecular biology. These products are designed for the diagnosis of and/or screening for... (more)


Beta: 1.51
Market Cap(Mil.): $273.44
Shares Outstanding(Mil.): 46.27
Dividend: --
Yield (%): --


  ENZ.N Industry Sector
P/E (TTM): 6.10 25.93 33.70
EPS (TTM): 0.97 -- --
ROI: 66.75 5.70 13.98
ROE: 68.53 9.04 14.91

BRIEF-S2G Biochem to collaborate with Mondelez for new sweetener process

* S2g Biochem announces collaboration with Mondelez International for new sweetener process

9:12am EDT

BRIEF-Enzo Biochem announces New York State Health Department approval of new cardiac assay

* Enzo Biochem announces New York State Health Department approval of new easily adaptable, cost effective cardiac assay

Sep 20 2016

BRIEF-Enzo Biochem files for mixed shelf of up to $50 mln

* Files for mixed shelf of up to $50 million - SEC filing Source: (http://bit.ly/2cd7ICi) Further company coverage:

Sep 01 2016

BRIEF-Enzo Biochem Q3 non-gaap loss per share $0.04

* Q3 revenue rose 10 percent to $26.4 million Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Jun 08 2016

BRIEF-Enzo Biochem reaches settlement with unit of Thermo Fisher

* Settlement does not affect unit's action brought in federal district court in new haven, ct against life technologies' predecessors

May 16 2016

Earnings vs. Estimates